Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain MetastasesDebu Tripathy, Cláudia Vieira, Nuhad K. Ibrahim et al.|JAMA Oncology|2022Cited by 24
Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratoriesEdwige Kasper, Claude Houdayer, Flavie Boulouard et al.|International Journal of Cancer|2025Cited by 4